Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28973549
Publication Date : //

A human patient-derived cellular model of Joubert syndrome reveals ciliary defects which can be rescued with targeted therapies.


Joubert syndrome (JBTS) is the archetypal ciliopathy caused by mutation of genes encoding ciliary proteins leading to multi-system phenotypes, including a cerebello-retinal-renal syndrome. JBTS is genetically heterogeneous, however mutations in CEP290 are a common underlying cause. The renal manifestation of JBTS is a juvenile-onset cystic kidney disease, known as nephronophthisis, typically progressing to end-stage renal failure within the first two decades of life, thus providing a potential window for therapeutic intervention. In order to increase understanding of JBTS and its associated kidney disease and to explore potential treatments, we conducted a comprehensive analysis of primary renal epithelial cells directly isolated from patient urine (human urine-derived renal epithelial cells, hURECs). We demonstrate that hURECs from a JBTS patient with renal disease have elongated and disorganized primary cilia and that this ciliary phenotype is specifically associated with an absence of CEP290 protein. Treatment with the Sonic hedgehog (Shh) pathway agonist purmorphamine or cyclin-dependent kinase inhibition (using roscovitine and siRNA directed towards cyclin-dependent kinase 5) ameliorated the cilia phenotype. In addition, purmorphamine treatment was shown to reduce cyclin-dependent kinase 5 in patient cells, suggesting a convergence of these signalling pathways. To our knowledge, this is the most extensive analysis of primary renal epithelial cells from JBTS patients to date. It demonstrates the feasibility and power of this approach to directly assess the consequences of patient-specific mutations in a physiologically relevant context and a previously unrecognized convergence of Shh agonism and cyclin-dependent kinase inhibition as potential therapeutic targets.

Authors : Srivastava Shalabh , Ramsbottom Simon A , Molinari Elisa , Alkanderi Sumaya , Filby Andrew , White Kathryn , Henry Charline , Saunier Sophie , Miles Colin G , Sayer John A ,

Related products :

Catalog number Product name Quantity
JHDM1D JBTS1 Gene Joubert syndrome 1
26-975 GPD1L belongs to the NAD-dependent glycerol-3-phosphate dehydrogenase family. Defects in GPD1L are the cause of Brugada syndrome type 2 (BRS2) and sudden infant death syndrome (SIDS). 0.05 mg
25-748 GPD1L belongs to the NAD-dependent glycerol-3-phosphate dehydrogenase family. Defects in GPD1L are the cause of Brugada syndrome type 2 (BRS2) and sudden infant death syndrome (SIDS). 0.05 mg
28-749 RelB is a member of the Rel_nuclear factor (NF)-kappa B family of transcription factors, defects in RelB affects antigen presenting cells and the formation of lymphoid organs. Targeted disruption of t 0.1 mg
28-593 RelB is a member of the Rel_nuclear factor (NF)-kappa B family of transcription factors, defects in RelB affects antigen presenting cells and the formation of lymphoid organs. Targeted disruption of t 0.1 mg
25-773 FERMT1 is involved in cell adhesion, possibly via its interaction with integrins. It may mediate TGF-beta 1 signaling in tumor progression. Defects in FERMT1 are the cause of Kindler syndrome. 0.05 mg
28-799 LMX1B is essential for the specification of dorsal limb fate at both the zeugopodal and autopodal levels. Defects in LMX1B are the cause of nail-patella syndrome (NPS) also knowan as Onychoosteodyspla 0.1 mg
EIAAB38363 E6-targeted protein 1,E6TP1,High-risk human papilloma viruses E6 oncoproteins targeted protein 1,Homo sapiens,Human,KIAA0440,Signal-induced proliferation-associated 1-like protein 1,SIPA1L1,SIPA1-like
25-038 MNX1 contains 1 homeobox DNA-binding domain. MNX1 is a putative transcription factor involved in pancreas development and function. Defects in MNX1 are a cause of Currarino syndrome. 0.05 mg
ARP55257_P050 RP11_529I10.4(deleted in a mouse model of primary ciliary dyskinesia) 50 µg
ARP55257_P050 RP11_529I10.4(deleted in a mouse model of primary ciliary dyskinesia) 50 µg
201-20-4953 RP11-529I10.4{deleted in a mouse model of primary ciliary dyskinesia}rabbit.pAb 0.2ml
KMCH135 Advanced Down Syndrome Baby Nursing Model
CSB-RP078874h Recombinant human Cellular tumor antigen p53 protein, Mol. Weight 45 KD, Source E. coli derived 10ug
CSB-RP078874h Recombinant human Cellular tumor antigen p53 protein, Mol. Weight 45 KD, Source E. coli derived 50ug
CSB-RP078874h Recombinant human Cellular tumor antigen p53 protein, Mol. Weight 45 KD, Source E. coli derived 1mg
CSB-RP078874h Recombinant human Cellular tumor antigen p53 protein, Mol. Weight 45 KD, Source E. coli derived 200ug
28-738 ZNF265 is a protein that has been shown to bind to the spliceosomal components U1-70K and U2AF35 and to direct alternative splicing. Analysis of the structure reveals substantial similarity to known R 0.1 mg
30-808 PRDX3 is a protein with antioxidant function and is localized in the mitochondrion. Expression of this gene product in E. coli deficient in the C22-subunit gene rescued resistance of the bacteria to a 0.05 mg
CSB-EL014641HU Human microphthalamia with linear skin defects (MLS) ELISA kit, Species Human, Sample Type serum, plasma 96T
CSB-EL006711HU Human defects in morphology 1 homolog (S. cerevisiae) (DEM1) ELISA kit, Species Human, Sample Type serum, plasma 96T
201-12-2204 Human targeted ribonuclease(TR)ELISA 96T
201-12-2204 Human targeted ribonuclease, TR ELISA 48T
CK-E96829 Human targeted ribonuclease, TR ELISAkit
H6918 TR (Targeted Ribonuclease), Human, ELISA Kit 96T


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur